Eugene Batuyong

Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study

Dawn Elizabeth Armstrong, Soundouss Raissouni, Julie Price Hiller et al. · Clinical Colorectal Cancer · 2015 · 68 citations

Medicine, Oncology, Surgery +17

Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab

Andrea S. Fung, Vincent C. Tam, Daniel E. Meyers et al. · Cancer Medicine · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Risk Factors for Venous Thromboembolism in Endometrial Cancer

Sophia Pin, Jennifer Mateshaytis, Sunita Ghosh et al. · Current Oncology · 2020 · 24 citations · Full text

Medicine, Oncology, Surgery +17

Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database

Haider Samawi, Hao‐Wen Sim, Kelvin Chan et al. · Cancer Medicine · 2018 · 20 citations · Full text

Medicine, Biostatistics, Oncology +17

Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database

Mohammed Abdullah Alghamdi, Carla Pires Amaro, Richard M. Lee‐Ying et al. · Cancer Medicine · 2020 · 15 citations · Full text

Medicine, Oncology, Pharmacology +13